Arbutus Biopharma Corp (ABUS)

3.395 +0.12 (+3.82%) USD  |  NASDAQ  |  Jan 07, 15:40
More

Arbutus Biopharma Cash and Short Term Investments (Annual): 126.00M for Dec. 31, 2023

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for ABUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Biomarin Pharmaceutical Inc 1.074B
Amicus Therapeutics Inc 286.20M
Ionis Pharmaceuticals Inc 2.331B
GlycoMimetics Inc 41.79M
FibroGen Inc 235.59M